Home / Cell Biology / Signal Transduction / Cytokine and NF-κB Signaling / NF-κB and IκB / NF-κB and IκB Inhibitors / CID 2858522

CID 2858522

Cat. No. 4246 1 Citation Submit a Review Datasheet / COA / SDS

Discontinued Product

4246 has been discontinued.

View all NF-κB and IκB products.
Description: Selectively inhibits PKC-induced NF-κB activation
Chemical Name: 1-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]ethanone
Purity: ≥98% (HPLC)
Datasheet
Citations (1)
Reviews
Pathways (1)
Biological Activity Technical Data Datasheets References

Biological Activity for CID 2858522

CID 2858522 is a selectively inhibits protein kinase C (PKC)-induced activation of the NF-κB pathway (IC50 < 0.1 μM for PMA-stimulated IL-8 production). Inhibits antigen receptor-stimulated NF-κB activation in chronic lymphocytic leukemia (CLL) B cells. Does not inhibit other NF-κB pathways, including that activated by tumor necrosis factor (TNF).

Technical Data for CID 2858522

M. Wt 465.63
Formula C28H39N3O3
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 758679-97-9
PubChem ID 2858523
InChI Key CYCGGKILBWERDJ-UHFFFAOYSA-N
Smiles OCCCNC2=NC1=CC(C)=C(C)C=C1N2CC(C3=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C3)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for CID 2858522

References are publications that support the biological activity of the product.

Peddibhotla et al (2010) Inhibition of protein kinase C-driven NF-κB activation: synthesis, SAR, and pharmacological profiling of pathway specific benzimidazole probe molecules. J.Med.Chem. 53 4793 PMID: 20481485

Shi et al (2010) Chemical biology strategy reveals pathway-selective inhibitor of NF-κB activation induced by protein kinase C and antigen receptors. ACS Chem.Bio. 5 287

View Related Products by Target

View Related Products by Product Action

View all NF-κB and IκB Inhibitors

Keywords: CID 2858522, CID 2858522 supplier, CID2858522, NF-kB, NF-kappaB, NF-κB, inhibitors, inhibits, PKC, protein, kinase, C-induced, activation, NF-kB/IkB, 4246, Tocris Bioscience

1 Citation for CID 2858522

Citations are publications that use Tocris products. Selected citations for CID 2858522 include:

Stec et al (2016) Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes. Oncotarget 7 31907 PMID: 27004406

Reviews for CID 2858522

There are currently no reviews for this product. Be the first to review CID 2858522 and earn rewards!

Have you used CID 2858522?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Pathways for CID 2858522

NF-κB Signaling Pathway

NF-κB Signaling Pathway

NF-κB signaling plays an important role in inflammation, the innate and adaptive immune response and stress. Dysregulated signaling can occur in inflammatory and autoimmune diseases.